… we recommend empiric corticosteroids while awaiting results of COVID-19 testing (table 1).
Corticosteroids can then be discontinued in the setting of a positive COVID-19 PCR test result…

… If further studies replicated the results seen in this report, the use of corticosteroids and
pulmonary rehabilitation in those with ongoing COVID-19 associated pneumonitis, to prevent the …

… that systemic corticosteroids reduce mortality in patients with COVID-19 needing invasive …
course of low dose corticosteroids proved to be safe in patients with non-severe COVID-19 (8). …

… for COVID-19 before starting empirical corticosteroids and for careful attention to be paid to
chest CT imaging to prevent potential exacerbation of COVID-19 in these high-risk patients. …

… with the use of corticosteroids, such as increased … dexamethasone therapy in all patients
with COVID-19 who require oxygen, further research is indicated in patients with COVID-19 who …

… aberrant immune response is key for inflammatory COVID-19 pneumonitis to develop as
shown by Lucas et al 34 in their longitudinal analyses of immunological response to COVID-19. …

… The major morbidity and mortality of hospitalized COVID-19 patients are attributed to
acute viral pneumonitis leading to acute respiratory distress syndrome (ARDS) [Citation1,Citation2,…

… immunotherapy; concomitant COVID-19 pneumonia and immune-related pneumonitis. In all
… with pneumonitis. Conversely, corticosteroids have a controversial role in COVID-19. They …

… transplant rejection, pneumonitis from autoimmune conditions, … dexamethasone in severe
COVID-19 is not drug specific but rather, the general anti-inflammatory effect of corticosteroids. …

… glucocorticoid dexamethasone is the standard of care in critically ill patients with COVID-19 …
As of this writing, in a hospitalized patient with COVID-19 who has evidence of pneumonitis …